icon-folder.gif   Conference Reports for NATAP  
 
  EASL 48th Annual Meeting
April 24th - 28th 2013
The Netherlands, Amsterdam
Back grey_arrow_rt.gif
 
 
 
SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/- RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY
 
 
  Reported by Jules Levin
48th Annual Meeting of the European Association for the Study of the Liver, Amsterdam, The Netherlands, 25 April 2013
 
Kris V. Kowdley1, Eric Lawitz2, Fred Poordad2, Daniel E. Cohen3, David Nelson4, Stefan Zeuzem5, Gregory T. Everson6, Paul Kwo7, Graham R Foster8, Mark Sulkowski9, Wangang Xie3, Lois Larsen3, Amit Khatri3, Thomas Podsadecki3, Barry Bernstein3
 
1: Digestive Disease Institute, Virginia Mason Medical Center, Seattle, WA; 2: The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX; 3: AbbVie Inc., North Chicago IL; 4: University of Florida College of Medicine, Gainesville, FL; 5: J.W. Goethe University, Frankfurt, Germany; 6: University of Colorado Denver, Aurora, CO; 7: Indiana University, Indianapolis, IN; 8: Queen Marys University of London, Barts Health, London, United Kingdom; 9: Johns Hopkins University, Baltimore, MD

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif